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Abstract 
Background: HIV/AIDS continues to be a major global public health problem with Eastern and Southern Africa 
being the regions most affected. With increased access to effective antiretroviral therapy, HIV has become a chronic 
and manageable disease, bringing to the fore issues of quality of life including mental wellbeing. Despite this, the 
majority of HIV care providers in sub-Saharan Africa, including Uganda’s Ministry of Health, do not routinely provide 
mental health care including depression management. The purpose of this paper is to explore stakeholders’ perspec-
tives on the feasibility and acceptability of integrating depression management into routine adult HIV care. The paper 
addresses a specific objective of the formative phase of the HIV + D study aimed at developing and evaluating a 
model for integrating depression management into routine HIV care in Uganda.
Methods: This was a qualitative study. Data were collected through in-depth interviews with 11 patients at enroll-
ment and follow-up in the pilot phase, and exit interviews with 11 adherent patients (those who completed their 
psychotherapy sessions) and six non-adherent patients (those missing at least two sessions) at the end of the pilot 
phase. Key informant interviews were held with four clinicians, five supervisors and one mental health specialist, as 
were three focus group discussions with lay health workers. These were purposively sampled at four public health 
facilities in Mpigi District. Data were analysed thematically.
Results: Patients highlighted the benefits of treating depression in the context of HIV care, including improved 
adherence to antiretroviral therapy, overcoming sleeplessness and suicidal ideation, and regaining a sense of self-
efficacy. Although clinicians and other stakeholders reported benefits of treating depression, they cited challenges in 
managing depression with HIV care, which were organisational (increased workload) and patient related (extended 
waiting time and perceptions of preferential treatment). Stakeholders generally shared perspectives on how best to 
integrate, including recommendations for organisational level interventions–training, harmonisation in scheduling 
appointments and structural changes–and patient level interventions to enhance knowledge about depression.
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Background
HIV/AIDS continues to be a major global public health 
problem, having claimed over 33 million lives so far, 
and with an estimated 38 million people living with the 
disease globally [1]. The Eastern and Southern Africa 
regions are the regions most affected by HIV, being home 
to more than a half (54%) of the total number of people 
living with HIV in the world and with a growing number 
of new infections [1].
With increased access to effective anti-retroviral ther-
apy (ART), HIV is gradually becoming a chronic and 
manageable disease with prolonged survival bringing 
issues of quality of life including mental wellbeing into 
the forefront [2–4]. Indeed, HIV/AIDS has been asso-
ciated with a number of mental health problems that 
include depression, anxiety disorder, alcohol use disorder, 
suicidality and neurocognitive disorders [5, 6]. In previ-
ous studies undertaken in the study area by this research 
group, rates of depression among HIV patients of 8 per-
cent in urban areas [5, 7], and 19.5 percent in rural areas 
[7] were observed. In both these studies the rates were 
higher in females than in males, at 15.6 percent versus 
8.2 percent [7], and at 9.6 percent versus 4.1 percent [5]. 
Depression in HIV/AIDS not only leads to severe psy-
chological distress, it has been associated with a number 
of negative clinical and behavioural outcomes [8].
Despite the importance of mental health problems, 
particularly depression, the majority of HIV care services 
in sub-Saharan Africa lack mental health care including 
services for treating depression [9]. Depression among 
people living with HIV and AIDS (PLWHA) continues 
to be a threat to the success of ART, hindering adherence 
and subsequently negatively affecting clinical outcomes 
[10, 11]. There is growing evidence of the high prevalence 
of depression and its damaging effects among PLWHA, 
and that this is partly attributable to absence of depres-
sion treatment in HIV care programs, severe shortage 
of mental health professionals and understaffing of the 
HIV clinics [5, 9, 12]. Indeed, in sub-Saharan Africa up to 
30 percent of depressive disorders have been associated 
with HIV/AIDS [8]. Depression among PLWHA not only 
affects quality of life [3], but has been associated with a 
number of other negative behavioural and clinical out-
comes such as more rapid HIV disease progression and 
mortality [13–15], poor adherence to HIV treatment, 
risky sexual behaviour and increased utilization of health 
facilities [8, 16, 17]. Indeed, global predictions indicate 
that both HIV/AIDS and depression will be the first 
two leading causes of disability globally by 2030 [18, 19]. 
Despite this, the majority of HIV care providers in sub-
Saharan Africa do not routinely provide mental health 
services including depression management [12, 20].
In a recent meta-analysis, a 31 percent pooled depres-
sion prevalence was found among PLWHA in Uganda, 
almost 10 times higher than the estimated prevalence in 
the general population [21]. With an estimated 1.4 mil-
lion people living with HIV/AIDS in Uganda, this poses 
a major challenge in HIV care despite the success in the 
scale up of ART and consequently increasing mortal-
ity [8, 22]. In response to this absence of mental health 
care in HIV programs, the Uganda National HIV and 
AIDS Strategic Plan (2015–2020) has called for the inte-
gration of mental health and other chronic conditions in 
HIV care so as to further improve the quality of care and 
treatment [22]. To operationalise this policy recommen-
dation, the Ministry of Health released guidelines for the 
treatment of HIV calling for the assessment and manage-
ment of depression as an integral part of HIV care pro-
grams [23].
Although the need for integrating HIV and men-
tal health services is indisputable, challenges exist in 
implementing a service integration model that is effec-
tive against mental disorders and is cost-effective to the 
health system [24]. Such a model should also be accept-
able and feasible for improving both mental health and 
HIV treatment outcomes. It is thus imperative that the 
model is informed by the perceptions and experiences of 
relevant stakeholders. There is limited data on the inte-
gration of depression management in HIV/AIDS in sub-
Saharan Africa. To date we are aware of only two studies 
that have been undertaken, the first being the INDEPTH-
Uganda Trial that was implemented in Uganda and eval-
uated two task-shifting approaches to depression care–a 
protocolised model versus a model that relies on the clin-
ical acumen of trained providers to provide depression 
care [9]. The second study was the COBALT Trial, 
which was undertaken in South Africa, and evaluated a 
nurse led depression integration model in HIV care [25]. 
While the COBALT trial has not published its results, the 
INDEPTH-Uganda trial found that protocolised delivery 
of therapy was superior to merely providing treatment 
guidelines.
Conclusions: Integrating depression management into routine HIV care in Uganda is acceptable among key stake-
holders, but the technical and operational feasibility of integration would require changes both at the organisational 
and patient levels.
Keywords: Depression, HIV, ART , Mental health, Uganda
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In support of the Ministry of Health policy recom-
mendation, the Mental Health Section of the Medi-
cal Research Council/Uganda Virus Research Institute 
& London School of Hygiene and Tropical Medicine 
Uganda Research Unit in partnership with the STD/
AIDS Control Program of the Ministry of Health is 
implementing a 5-year study named HIV + D Trial. The 
HIV + D Trial aims to develop and evaluate at trial a 
model for integrating the management of depression into 
routine HIV care in Uganda [26]. This proposed HIV + D 
Trial will evaluate the effectiveness and cost-effectiveness 
of a stepped care depression integration model that will 
be delivered by the HIV care team at Public Health Care 
Facilities (PHCFs) in partnership with lay health work-
ers who will be derived from either members of the vil-
lage health team (VHT; the first level of the Ugandan 
health care system) or lay health workers (expert clients 
living with HIV). The intervention will be coordinated 
by the existing HIV counsellors (general nurses who 
have received training in HIV counselling, working at 
PHCFs), and will be supported by mental health profes-
sionals (psychiatric clinical officers or psychiatric nurses) 
based at Health Centre IVs (health sub-districts serving 
as referral centres for lower health facilities), district and 
regional referral hospitals. This paper is based on data 
from the formative phase of the HIV + D intervention 
that has already been implemented, whose principal aim 
was to develop an intervention model for the HIV + D 
trial. In this paper, we explore stakeholders’ perspec-
tives on the feasibility and acceptability of integrating the 
management of depression into routine adult HIV care in 
Uganda.
Theoretical framework
Our choice of theoretical model of integrated care 
derives from what has been referred to as realist mod-
els. Although we did not identify previous similar studies 
that have used the realist model, we consider the model 
suitable for guiding the research. Realist models generally 
highlight the significance of context in developing inte-
grated care programmes that achieve desired outcomes 
[27]. With a grounding in empirical evidence these mod-
els seek to lay out realistic pathways to successful integra-
tion by, for example, identifying the contextual variables 
(such as strong leadership and organisational culture) 
that would be key for successful integration in a specific 
programme area (for instance institution of multidiscipli-
nary teams) [28].
Two main considerations influenced this choice. First, 
realist models provide for contextual specificity. This ena-
bled us to draw on our observations during the forma-
tive study (on which this paper is based) undertaken at 
four public health facilities, from which practical lessons 
were drawn in order to verify what aspects of integration 
were considered acceptable/unacceptable. Second, inte-
gration within realist frameworks is targeted at specific 
programmes/services (in our case, integrating the man-
agement of depression into routine HIV care).
Accordingly, our concept of integration for the purpose 
of this paper is the one that engenders establishment of 
multi-purpose health service delivery points in one loca-
tion, providing different clinical and related services to 
a catchment population [29]–in this case, HIV patients 
who may need depression-related care in addition to 
their regular HIV-related services. Such integration 
therefore is essentially aimed at addressing disjointedness 
and promoting coordinated care in the provision of ser-
vices so that the user can easily navigate the varied ser-
vices that they need on a single trip to the facility [29].
We also find Benzer and colleagues’ [30] theoretical 
perspectives on factors influencing success of integrated 
care pertinent to our purpose. In their grounded theory 
on integration of mental health services into primary 
care the authors identify, among others, organizational 
factors (including resources, training and work design), 
provider experiences (such as time pressures arising from 
redistribution of workloads) and patient factors (concep-
tualized as the surrounding environment) as key in shap-
ing success of integration.
In this paper we will draw on these theoretical perspec-
tives to interpret and discuss our findings.
Methods
Design
This was a qualitative study, part of the broader forma-
tive phase of the HIV + D intervention whose general 
objective was to develop and evaluate a model for the 
integration of depression management into routine HIV 
care in Uganda. The formative phase was guided by three 
specific objectives: i) to adapt the MANAS intervention–
a stepped-care collaborative model for the integration 
of mental health care into primary health care that was 
successfully evaluated in India–to the Ugandan HIV care 
context; ii) to adapt the Healthy Activity Program (HAP) 
[31], a form of Behavioural Activation Therapy. The HAP 
is a brief psychological treatment for depression that was 
successfully evaluated in India–to the Ugandan HIV care 
context; and iii) to evaluate the acceptability and feasi-
bility of an intervention that will integrate the manage-
ment of depression into routine HIV care in Uganda (the 
“HIV + D” intervention). By exploring stakeholders’ per-
spectives on the feasibility and acceptability of integrat-
ing the management of depression into routine adult HIV 
care in Uganda, this paper directly addresses Specific 
Objective III of this formative phase.
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The HIV + D intervention
The HIV + D intervention was a stepped care collabora-
tive model that was initially conceived to be delivered 
in three steps, and uniformly across the three levels of 
health care (III, IV and district hospital) where the inter-
vention was implemented. At all these levels the focal 
point was the HIV clinic. The intervention is summarised 
in Fig. 1 below.
Study setting
This formative study was undertaken at four public 
health care facilities (PHCFs) in Mpigi District in central 
Uganda, a district that has had a long term relationship 
with MRC/UVRI and LSHTM Uganda Research Unit. 
The four selected PHCFs represented three levels of the 
Ugandan health care system: Butoolo and Buwama, with 
level three health centres (HCIII); Mpigi, with level four 
health centres; and Nkozi, with a hospital level health 
facility. Mpigi district is a semi-urban, densely populated 
district with both urban and rural populations. The dis-
trict comprises 19 PHCFs which offer varying levels of 
care, graded as HCI, II, III, IV and a hospital, with the 
latter three HC levels (where the intervention was deliv-
ered) offering the same services. The HCIV (Health sub-
district) serves as the referral point for the lower HCs. 
The health facilities run HIV clinics weekly. These clin-
ics are staffed with general health workers, counsellors 
and lay health workers (expert clients who live with HIV 
and support other PLWHA). At the lowest level (HCI) 
within each village, volunteers from within the com-
munity are nominated by community members to form 
Village Health Teams (VHTs) entrusted with taking care 
of health matters of villages where they live. There is no 
built structure or qualified health staff at this level.
It was important to get a perspective from each of these 
levels of care for two reasons. First, these different levels 
represent the range of HIV care services in the country. 
Second, the perspectives from the different levels were to 
inform the proposed HIV + D trial that was to be under-
taken in 40 PHCFs represented by these levels of care.
Study participants
Multiple stakeholders including mental health specialists, 
healthcare workers (clinicians), and service users (includ-
ing PLWHA) were purposively sampled for inclusion in 
development of the HIV + D intervention. These were 
involved at the different levels (HCIII, IV and the district 
hospital) of the health care system where the study was 
undertaken. For the depressed PLWHA, eligibility for 
inclusion in the study was (i) an HIV positive status with 
evidence of a certificate, (ii) registration with an HIV 
clinic in Mpigi district, (iii) being 18  years and above, 
(iv) ability to communicate in either English or Luganda 





Assessment of clients’ 
depression scores. Those with 
scores of ≥10 on Patient Health 
Questionnaire-9 (PHQ-9) to be 
given psychoeducation by lay 
health workers or referred to 
mental health specialist if with 
scores of ≥20
Week 4
If PHQ-9 score ≥ 5, lay health workers 
at the 3 HC levels to start Behavioural 
Activation/psychotherapy for clients 
who opt this, which would be 
delivered in 6 sessions over 12 weeks
Week 4
If PHQ-9 score ≥ 5, HIV clinicians 
at the 3 HC levels to start 
antidepressants for clients who opt 
this, which would be delivered daily 
for 6 months
A client who remains symptomatic at 
the end of treatment (offered at Step 
II) or presents with scores of ≥20 at 
Step 1 is referred to a mental health 
specialist (a psychiatric clinical 
officer or psychiatric nurse). If the 
specialist not available on site, client 
is referred to nearest PHCF where 
such specialist is available 
Fig. 1 The stepped care (HIV+D) intervention
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Questionnaire-9 (PHQ-9) [32] of 10 and above. For the 
other stakeholders, those eligible for inclusion were 
the ones participating in the delivery of the HIV + D 
intervention.
In pursuit of Specific Objective III of the formative 
phase (to evaluate the acceptability and feasibility of an 
intervention to integrate the management of depres-
sion into routine HIV care in Uganda) which we directly 
address in this paper, data were collected from three cat-
egories of participants: (i) the Healthy Activity Program/
Behavioural Activation (BA) core team that delivered 
BA psychotherapy–these were the lay health workers 
who were also living with HIV and supervised by an HIV 
counsellor or nurse; this core team was supported by 
mental health specialists, (ii) clinicians who delivered 
antidepressants and (iii) study participants (depressed 
PLWHA) who were attending ART clinic (at the four 
selected public health care facilities) with moderate/
severe symptoms of depression (those scoring 10–19 on 
the Patient Health Questionnaire-9 [PHQ-9], which was 
validated in Uganda) and had been purposively selected 
to participate in the HIV + D intervention. Information 
on sample sizes for the different categories of partici-
pants is summarised on Table 1 below.
Data collection procedures
Using semi-structured interview topic guides, in-depth 
interviews were conducted with PLWHA, key informant 
interviews were conducted with clinicians, supervisors 
and a mental health specialist, and focus group discus-
sions were held with lay health workers (expert clients). 
Additionally, exit interviews were conducted with adher-
ent and non-adherent HIV patients–it is worth noting 
that we registered non-adherence among the PLWHA 
receiving psychotherapy and none among those on 
antidepressants. These exit interview participants were a 
subset of PLWHA attending ART clinic but who had not 
been interviewed. More information on data collection 
processes and topics covered is highlighted on Tables  1 
and 2 below.
All interviews and focus group discussions were con-
ducted/moderated by research assistants who were psy-
chiatric nurses, and were audio taped and transcribed 
verbatim. Interviews and focus group discussions with 
patients and lay health workers were conducted/moder-
ated in the local language (Luganda). These were then 
transcribed in Luganda and translated to English by the 
interviewers/moderators who conducted the respective 
interview/focus group discussion. Interviews with clini-
cians and supervisors were conducted and transcribed 
in English. The interviews on overage lasted 45 to 60 min 
while focus group discussions lasted one to two hours.
Data analysis
Two experienced qualitative researchers conducted 
the data analysis at different time periods. The first 
researcher conducted a data-driven analysis aimed at 
an initial in-depth exploration of the data. Building on 
the output from this analysis, the second researcher 
conducted an analysis driven by the specific research 
objective related to the feasibility and acceptability of 
integrating the management of depression into rou-
tine HIV care. The outputs of the analysis from the two 
researchers were reviewed by the study team and found 
to be generally consistent and accurate.
The data were analysed using thematic analysis tech-
niques, which involve the identification, analysis, organ-
isation, description, and reporting of themes found 
within a data set [33]. The data were coded with the help 
of a thematic framework initially developed from the 
Table 1 Summary of participant recruitment and data collection exercises












HIV patients (PLWHA) 131 (100 females; 31 males) Serial in-depth interviews with 6 HIV 
patients on psychotherapy and 5 on 
antidepressants
11 11 8
Exit in-depth interviews with 11 adherent 
(those who completed all the psycho-
therapy [n = 9] and antidepressant [n-2] 
sessions) and 6 non-adherent (those 
who missed ≥ 2 sessions) HIV patients. 
These had not been interviewed
17
Lay health workers 8 (5 females; 3 males) Serial focus group discussions (FGDs) 1 FGD 1 FGD 1 FGD
Clinicians 4 males Serial key informant interviews 4 4 4
Supervisors 4 (3 males; 1 female Serial key informant interviews 4 3 3
Mental health specialists 4 Serial key informant interviews 0 0 1
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emerging themes and refined based on concepts bor-
rowed from our theoretical framework. Using MS Excel, 
the key themes and sub-themes in the thematic frame-
work were classified on a matrix, which was then used 
to capture relevant pieces of data that illustrated the 
themes.
Results
In the findings below we present perspectives of the cross 
section of stakeholders on the acceptability and feasibility 
of integrating the management of depression into routine 
HIV care in Uganda. It is worth noting that stakeholders’ 
perspectives on feasibility related to only two aspects: the 
technical aspect, in which we sought to assess whether 
the organisation has the necessary technical resources, 
including expertise, for successful implementation of the 
integrated model; and the operational aspect by which we 
examined how integration fits within the existing envi-
ronment, with a focus on suitability of the public health 
care facilities’ physical infrastructure for implementing 
the integrated model. Also noteworthy is that while there 
was no noticeable variance in perspectives among the 
different stakeholder categories, concurrence was most 
evident among patients and clinicians who were the most 
outspoken with regard to their positive attitudes towards 
acceptability and feasibility of integration (Fig. 2).
Benefits of treating depression within the context of HIV 
care
Irrespective of choice of treatment, participants gener-
ally had a positive view about the impact of depression 
treatment within the context of HIV care. This view was 
mainly expressed by PLWHA but was notably also ech-
oed by other stakeholders including supervisors and lay 
health workers. It is against this backdrop that PLWHA 
Table 2 Topics covered during interviews/focus group discussions with participants
Participant category Topics covered during interview/focus group discussion
PLWHA At baseline: depression awareness, depression treatment experiences and feasibility of 
integration
At midline: experiences with those delivering the treatment, challenges during treat-
ment and recommendations for change
At endline: changes in health since the last therapy session, challenges encountered, 
what worked/did not work well and recommendations for change
Adherent and non-adherent HIV patients (a subset of PLWHA 
who had not been interviewed) participating in exit inter-
views
Experiences and reasons for adherence/non-adherence
Lay health workers At baseline: perspectives on depression and psychotherapy, the process of delivery of 
psychotherapy, and feasibility of integration
At midline: experiences and challenges of delivering psychotherapy and recommen-
dations for improving the treatment, ease of applying decision support algorithm
At endline: experiences of managing depression and with patients, challenges of man-
aging depression and perspectives on integration, ease of applying decision support 
algorithm
Clinicians and supervisors At baseline: depression prevalence, patients’ care-seeking behaviour, experiences with 
depression patients, perspectives on antidepressants and its delivery, and integration
At midline: experiences and challenges of delivering antidepressants, ease of applying 
decision support algorithm and recommendations for improvement in treatment 
delivery
At endline: experiences of depression management, barriers of treatment delivery and 
recommendations, ease of applying decision support algorithm and perspectives on 
challenges and opportunities of integration
Mental health specialists Experiences of depression management, barriers of treatment delivery and recommen-
dations, and perspectives on challenges and opportunities of integration
Fig. 2 Conceptual figure highlighting the themes emerging from the 
data and their relationships
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persistently called for the harmonisation of HIV and 
depression services as expressed in the following two 
excerpts:
“I think it would be good [to] see how best you can 
integrate depression treatment into our routine HIV 
care. I am sure that after this study, these medical 
forms will eventually be put into our ART files so 
that those health workers will be able to know that 
we are on treatment for depression. So the treat-
ments can be harmonized such that we are given the 
same appointment dates for antidepressants and 
ART” (Nkozi, Antidepressants, Patient 1, Midline 
Interview).
“I suggest that at every ART facility there should be 
enough health workers trained to handle depression 
… because it would be fair if every person coming 
for their ART refills can be assessed and treated for 
depression. It will also help patients who are failing 
to suppress because of depression” (Buwama, Psy-
chotherapy 1, Endline Interview).
We viewed these findings as a strong indicator of the 
acceptability of integrating depression treatment within 
HIV care.
We also note that the positive feedback from stake-
holders as earlier noted was shared mostly at endline 
and often at midline, although there were a few cases in 
which patients shared the feedback at the baseline inter-
view (immediately preceding the start of psychotherapy 
or antidepressant medication). In these cases, the patient 
had registered early benefits from the psychoeducation 
(as described earlier in the methods), an initial single 
session depression therapy that was offered to all partici-
pating patients as a first step towards the intervention. 
Patients consistently highlighted a number of physical 
and mental health benefits of depression treatment.
Improving ART adherence
Perhaps the most pertinent benefit of depression treat-
ment was that it potentially enhanced HIV treatment 
outcomes by improving ART adherence. With regard to 
improving adherence, our analysis reveals both direct 
and indirect pathways through which this occurred. 
One of the direct pathways was that depression treat-
ment helped the despondent patient regain hope in their 
wellbeing.
“[As a result of my treatment for depression] I have 
also been able to regain my hope. I no longer fall 
sick very often like how it used to be earlier on before 
being enrolled into this study”(Buwama, Psychother-
apy 1, Endline Interview).
This hope was usually accompanied by a renewed dis-
position on the part of participants to adhere to their 
ART regimen. Reflecting on her own depression treat-
ment experience, the same participant credited the treat-
ment for improved ART adherence, and ventured further 
to strongly recommend the treatment to anyone living 
with HIV as a way to avoid poor adherence to ART treat-
ment which may lead to the clinician putting you on sec-
ond line ART.
“Depression treatment [counselling] is very helpful 
among people living with HIV/AIDS. If you have not 
been taking your medication well it helps you to take 
it and you end up feeling well…. So I would strongly 
recommend that all people living with HIV/AIDS 
should receive this [depression] treatment. If that is 
done we shall have few people on second line treat-
ment regimen which is hard to get… yet the number 
of people on second line is increasing” (Buwama, 
Psychotherapy 1, Endline Interview).
On the other hand, one of the indirect pathways 
through which depression treatment would lead to 
improved ART adherence, according to some patients, 
was by easing disclosure in discordant relationships. 
Non-disclosure was considered to be a significant bar-
rier in ART adherence in a sense that treatment doses 
were sometimes administered late or even skipped if 
the environment was not discreet enough to facilitate 
administration of the dose without the partner’s aware-
ness. For patients in this situation therefore, disclosure 
was an imperative for enhancing adherence and their 
own health. Yet for one of these patients, for example, the 
act of disclosing was complicated further by earlier indi-
cations from the partner that she would abandon him if 
they were found to be discordant and she is negative. This 
participant credited the psychotherapy associated with 
depression treatment for having equipped him with the 
skills and courage to disclose.
“For my case the cause of depression was that I was 
in a discordant relationship in which I was HIV pos-
itive yet my wife was negative [and she did not know 
my status]. So that kept me worried about how I 
would break such disturbing news to her…. And also 
basing on the statements that she used to make that 
“in case we test… and I am found negative when he 
is positive, I will just divorce him”…. It is from this 
study that I acquired skills to disclose to her. Eventu-
ally I informed her about my status…. (Nkozi, Psy-
chotherapy 2, Nkozi, Baseline Interview).
Besides improving ART adherence, participants 
described other experiences in which psychotherapy 
enhanced HIV treatment outcomes. This was particularly 
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so in instances where a patient was adhering to the ART 
regimen and still would not register viral suppression, but 
did show viral suppression after psychotherapy, in which 
case psychotherapy was considered as having enabled the 
body to respond better to ARVs.
“They used to tell me that I was taking my ARVs 
badly; they even thought I was taking alcohol yet 
I was not. But after receiving psychotherapy, I was 
amazed when the clinicians told me that I was tak-
ing my medication well. That amazed me a lot 
because for seven years I had never suppressed, 
not until now. However, I realized that [before psy-
chotherapy] I used to take my ARVs but would 
still worry a lot and even keep thinking about sui-
cide – so that made me not to suppress the virus” 
(Buwama, Adherent 2, Exit Interview).
Overcoming sleeplessness and suicidal ideation
Another reported benefit of depression treatment was 
that it helped overcome sleeplessness. This apparently 
was the most frequently cited benefit. With the excep-
tion of one who experienced acute side effects from 
antidepressants and had to discontinue the therapy, par-
ticipants from both the antidepressant and the psycho-
therapy groups were unanimous in their view that the 
treatment had markedly improved their sleep and general 
wellbeing.
“Before I was initiated on that [depression] treat-
ment, I would go to bed and keep awake –with no 
sleep and I would have intrusive thoughts of why I do 
not die and leave this world. I used not to have sleep 
at all. I would only sleep when it was approaching 
daytime, but when I started the treatment, I can 
now sleep soundly and the bad thoughts I used to 
have are no more” (Butoolo, Antidepressants, Mid-
line Interview).
This view was echoed by supervisors, as one noted:
“Yeah because those on treatment… were not sleep-
ing at first but after putting them on treatment they 
were now sleeping well. Some were not eating after 
treatment they started eating well and doing their 
work as usual” (Buwama Supervisor, Endline Inter-
view).
Perhaps as a knock-on effect of being able to sleep 
normally and to avoid too many thoughts, several par-
ticipants also talked about having overcome suicidal 
ideation.
“The [antidepressant] tablets are good…. I never 
used to sleep but now I can. The second benefit [of 
depression treatment] is that I used to have bad 
thoughts of taking many ART tablets [attempting 
suicide] so that I die since I was living alone. For-
tunately, I no longer have them, and feeling lonely 
has reduced” (Mpigi, Antidepressants, Midline 
Interview).
“I used to lack sleep but right now I sleep well, I 
used to lack appetite but now I have a lot of appe-
tite…. The tablets also helped me to overcome the 
many thoughts that I used to have such as suicidal 
ideations and thoughts on self-isolation” (Nkozi, 
Antidepressants, Patient 1, Endline Interview).
Regaining a sense of self‑efficacy
The other notable benefit of depression treatment was 
that treatment recipients regained a sense of “self-effi-
cacy,” that is, a belief in one’s own ability to influence 
events that affect their lives [34]. This was perhaps 
not surprising given the generally positive outlook 
that majority of participants projected in their feed-
back on the treatment. Participants observed that the 
treatment enabled them to regain control over their 
lives by empowering them with knowledge about a 
health condition (depression) they suffered from but 
did not understand, and by instilling in them a belief in 
their own agency in the efforts to resolve their health 
problems.
“I used to think a lot and I would end up falling sick 
because of those many thoughts but nowadays that 
no longer happens, because I have applied some of 
the skills that I learnt during counselling [psycho-
therapy] such as, letting things go, avoiding over-
thinking, breathing in and out in order to relax…. 
However, I also believe that if I happen to experience 
any signs and symptoms I will be able to overcome 
them before they cause much harm to me. I now also 
understand depression illness in detail, I have learnt 
how to overcome it” (Buwama, Psychotherapy 1, 
Endline Interview).
This sentiment was also highlighted during a group dis-
cussion with lay health workers, with one of the partici-
pants noting:
“Counselling [psychotherapy] has helped patients a 
lot because… those who are being discharged act as 
ambassadors after they have learnt how to overcome 
their problems. Psychotherapy helps to empower 
someone with skills that help them to encounter any 
future challenges/problems” (Focus Group Discus-
sion with Lay Health Workers, Midline).
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Challenges arising from managing depression with HIV 
care
While the feedback from those receiving treatment for 
depression was overwhelmingly positive, our analysis 
of data revealed potential barriers to the integration of 
depression management into routine HIV care. Draw-
ing on their own experiences from the study, clinicians 
from the four study sites were unanimous in their view 
that the integration presented some challenges that 
impacted both patients and clinicians. These chal-
lenges were mainly organisational factors, particularly 
increased workload for clinicians, and patient factors 
including extended waiting time at the health facility 
and patients’ perception of preferential treatment.
Organisational factors
Clinicians cited a key organizational factor in the form 
of increased workload and associated time pressures 
as one of the key challenges to integrating depression 
management into routine HIV care. They acknowl-
edged that the addition of depression care onto their 
already stretched schedule of HIV care would increase 
burnout, at least in the short term. This ordinarily 
would have engendered the clinicians’ disinclination 
towards the integrated service delivery model. How-
ever, what was also notably apparent in the clinicians’ 
narratives around increased workload was that they 
maintained a positive attitude towards integration of 
the two services, and expressed willingness to adopt 
the model. For some clinicians, adoption of the inte-
grated model despite the increased workload was justi-
fied given that this would likely benefit them by making 
work less demanding in the longer term than under 
the current model. One clinician noted, for example, 
that the increased workload would be easier to man-
age than having patients whose HIV viral load was not 
suppressed, itself the function of untreated depression 
among the HIV patients.
“Ah… work load! I do not want to say it because 
it is easier to manage. As for me the time I have 
managed this depression and HIV and now a third 
element of non-suppression [non suppression of 
HIV viral load], it is easier to manage a depres-
sive patient, and it is very important to deal with 
a depressive patient than with one whose HIV viral 
load is not suppressed…. When someone’s HIV 
viral load is suppressed it saves time; we just give 
them drug refills. However for those whose HIV 
viral load is not suppressed we have to go into 
clinical management including investigating why 
their HIV viral loads are high. So when you man-
age depression it will be like a short cut for you 
to get a suppressed patient. So as for me, I do not 
see it as a work load, we just need to appreciate 
it and when we do it well we shall be saving the 
time which we would have spent on the non-sup-
pressed…” (Butoolo Clinician, Midline Interview).
Another clinician highlighted the magnitude of the 
increased workload but implied that this was acceptable 
since the workload was expected to reduce with time.
“That is a challenge because sometimes you have 
over 100 clients in a day – you have to get time and 
also attend to others [and] counselling [psychother-
apy] needs time …. You know it is quite challenging… 
like you have just started to come in, you feel that 
you have added some extra work. But as time goes 
on, you get used actually, you go on adjusting slowly 
by slowly in fact at the end of the day you find that 
you have not added any extra work. So the screening 
process becomes simple and easier, then the counsel-
ling process [psychotherapy] is also decreasing and 
you get used to it” (Mpigi Clinician, Endline Inter-
view).
Patient factors
Extended waiting time. The extended time spent wait-
ing at the clinician’s office was identified as one of the 
key patient related challenges of integrating depression 
into HIV care. Clinicians worried that longer waits than 
was the case before integration would in turn generate 
discontent among patients who might perceive this as a 
deterioration in the quality of care. This perception was 
particularly likely among those visiting for a simple pro-
cedure, such as an HIV viral load check, but are being 
made to wait much longer. One clinician observed:
“So now it could be time for the [other] client to get 
the assessment but the time you spend assessing 
depressed clients you alter the time for the other cli-
ent who just came probably for a viral load check 
and should be gone quickly. So someone who would 
have spent 15-20 minutes at the facility may end up 
waiting 30 minutes. So I think that will affect the 
routine flow and again that is waiting time mainly” 
(Buwama Clinician, Baseline Interview).
On the same note, a lay health worker observed:
“You actually need a lot of time to speak to a 
depressed client… some cry during the sessions and 
as such you have to give them time to do so…. Some-
times you would have like three patients waiting for 
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you to see them, and as a result these other patients 
would end up waiting for long periods of time” 
(Focus Group Discussion with Lay Health Workers, 
Endline).
Patients’ perception of preferential treatment. Another 
key patient related challenge of integration was the 
patients’ perception that clinicians were giving preferen-
tial treatment to other patients, which resulted in longer 
waits at the clinician’s office. For example, one clinician 
was concerned that some patients, especially those that 
have already been waiting for long, might feel ignored 
when they see their counterpart who is depressed and in 
need of urgent doctor’s attention being prioritised over 
them.
“…that was a challenge–for example I have a queue 
there, clients have been waiting and this client comes 
in and of course she may need immediate attention 
which I was not able to give to them…. The other 
ones may see it as [giving others preferential treat-
ment]” (Nkozi Clinician, Midline Interview).
How best to integrate depression management 
into routine HIV care
While stakeholders spoke highly about the benefits of 
integrating depression management into routine HIV 
care, they also identified some necessary conditions for 
the successful operationalisation of this service delivery 
model. We identified mainly two of these conditions, 
namely organisational (including training to enhance 
clinical expertise, harmonisation in scheduling appoint-
ments, and structural changes) and patient level inter-
ventions to enhance knowledge of depression. We viewed 
the possible fulfilment of these conditions, which might 
not require heavy resource investment, as indicative of 
the feasibility of integrating depression treatment into 
routing HIV care.
Organisational level interventions
Training to enhance clinical expertise. At the organisa-
tional level, one of the key conditions for the success-
ful operationalisation of the integrated service delivery 
model was training to enhance clinicians’ competence in 
delivering both HIV and, especially, depression care. This 
suggestion came particularly from clinicians, who had a 
background in HIV care and would be expected to man-
age depression among their HIV patients. The training 
reportedly would address the current knowledge/skills 
gap among clinicians, including an understanding of 
depression as a common comorbidity among HIV clients.
“I think everything will be based on the staff and 
they should acknowledge the new program [inte-
grated services], they should be able to know that 
really this [depression] happens, people with HIV 
can have depression concurrently, and then as I said 
we need continuous refresher trainings… because 
mental health is not an easy thing though you can 
look at it and you think it is easy. It is not an easy 
thing” (Buwama Clinician, Baseline Interview).
Training was also considered critical in the area of 
depression medications. In this case clinicians were con-
cerned about their current inability to provide the best 
advice given their limited knowledge about the available 
drugs, particularly their side effects, their potential inter-
actions with ART and their toxicity. One clinician high-
lighted some of these concerns:
“… of course as you know about the tricyclic antide-
pressants they have [a] side effect–they can cause 
death; they are fatal if given in overdoses [and] for 
the [HIV] clients there is also taking Nevirapine and 
antidepressants. Now for Nevirapine, it reduces the 
concentration so you need to give a high dose of anti-
depressant” (Nkozi Clinician, Baseline Interview).
The same clinician speaks to the current knowledge 
gaps among clinicians:
“These drugs… do not have a clear literature about 
them. Though [for] fluoxetine they say it is safe in 
pregnancy they do not [provide] clear literature, so 
my challenge may come in giving antidepressants to 
pregnant mothers and lactating ones….”
Harmonisation in scheduling appointments. In their 
narratives on changes needed at the organisational level, 
stakeholders–including patients and supervisors–essen-
tially talked about the need for harmonisation in HIV 
and depression care. This, they proposed, would be 
achieved in different ways, including a departure from 
the current system in which the scheduling of clinician’s 
appointments assumes no correlation between HIV and 
depression. They argued that appointments for these two 
conditions need to be coordinated so that the patient can 
access treatment for both conditions on a single trip to 
the health facility.
“It [clinician’s appointment for depression care] 
should actually depend on the period that you are 
given for the ART, say if you are given for three 
months, also the antidepressants should be given 
for three months such that the appointment dates 
are harmonized” (Nkozi, Antidepressants, Patient 1, 
Midline Interview).
“The biweekly [psychotherapy] appointments [for 
depression care] might be a challenge but I believe if 
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we make it on a monthly basis so that if the patients 
come for ART treatment they even get depression 
treatment on the same day it will be easy for them to 
keep the appointment dates” (Focus Group Discus-
sion with Lay Health Workers, Endline).
Structural changes. Consistent with patients’ perspec-
tives, some clinicians suggested structural changes in 
order to resolve the current disjointedness in service 
delivery, whereby HIV clinics are physically delinked 
from those for managing depression. These argued for 
more coordinated service delivery in the form of central-
ised physical spaces or what they referred to as one-stop 
centres, where patients would conveniently access both 
HIV and depression care.
“I would prefer to have a one-stop centre for care. 
Like I am depressed, I need ART, [and] I get them 
from this dispensing window. Are you getting it? 
[But] now I would have to go to OPD to get the anti-
depressants because it can be dispensed in the OPD 
unlike the HIV drugs which cannot be dispensed 
anywhere…. I am suggesting that the dispensing log 
should also include the amitriptyline [antidepres-
sants] here at the ART clinic so that when a client… 
comes here [s/he] does not need to go to another dis-
pensing point” (Buwama Clinician, Midline Inter-
view).
Patient level interventions to enhance knowledge 
of depression
Another necessary condition for successful integration 
of depression management into routine HIV care was to 
do with service users/patients. Stakeholders, particularly 
clinicians and patients, recognized that patients were 
sometimes not informed about depression as a health 
condition and needed to appreciate this reality in order 
for them to embrace the appropriate treatment. The 
stakeholders recommended enhancement of knowledge 
of depression among patients through educational and 
other awareness-raising interventions. They emphasized 
the need for health education targeted at the patients and 
the broader public through mass media, village sensi-
tization meetings as well as patient follow-up to ensure 
understanding of depression and the related medication 
they were being asked to take.
“I think informing the public through mass media 
such as televisions and radios can be of help…. Also 
holding sensitization meetings in the villages can be 
of great help” (Buwama, Antidepressants, Patient 2, 
Midline Interview).
“… we have to strengthen our follow up strategies 
that is the only way. Health education packaging… 
you know [so the] client understands why he takes 
the medicine and for how long. Then you make sure 
you make constant follow-up. You ensure follow 
up, they will be ok…” (Buwama Clinician, Baseline 
Interview).
Aside from the organisational and patient level inter-
ventions that are necessary for success of integration, our 
formative research yielded some pertinent findings that 
pointed to necessary changes in the mode of delivery 
of depression management. These changes, which have 
now been incorporated in the HIV + D trial, relate to the 
decision support algorithm for the stepped care HIV + D 
intervention. While implementing the three-step inter-
vention during the formative research, we observed that 
majority of participants who proceeded to Step II of the 
algorithm (57 out of 66 patients) preferred Behavioural 
Activation (psychotherapy) to antidepressant medication. 
For the purpose of the HIV + D trial, we have designed 
a more client-friendly decision support algorithm that 
provides for delivery of psychotherapy at Step II to all 
the participants who do not improve at Step I. This is 
instead of the earlier algorithm which gave patients the 
choice between psychotherapy and antidepressants at 
Step II. Consequently, antidepressant medication will 
now be provided together with psychotherapy at a higher 
level (Step III) for those patients whose depression scores 
remain high. Under the current algorithm, the stepped 
care intervention has four levels with referral to a mental 
health specialist being done at Step IV. We consider this 
adjustment in the decision support algorithm a necessary 
step in enhancing the feasibility of integrating depression 
into HIV care.
Discussion
In this paper we explored stakeholders’ perspectives on 
the acceptability and feasibility of integrating the man-
agement of depression into routine HIV care in Uganda, 
drawing on data from PLWHA, clinicians, supervisors, 
lay health workers, and a sub-group of PLWHA, that 
is, adherent and non-adherent patients. Our findings 
demonstrate that integration, modelled along a realist 
approach that allows for contextual specificity and targets 
particular services, is acceptable among the stakehold-
ers. This was more evidently so among those stakehold-
ers who held the most direct stake in integration (service 
users [PLWHA] and clinicians), who credited the pilot 
intervention for improving ART adherence, overcoming 
sleeplessness and suicidal ideation, and regaining a sense 
of self-efficacy. These findings lend further credence to 
broader calls for integration of mental healthcare into 
primary healthcare as the strategy for addressing the 
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significant unmet need for effective mental health ser-
vices in low and middle income countries [35].
In the sub-Saharan African context where research on 
integrating services is still limited [36], the findings from 
this study contribute in strengthening the current evi-
dence base to inform best practices in integrating depres-
sion management in HIV care. We have shown that 
stakeholders’ positive attitude towards integration was 
driven by a number of associated benefits, key among 
which was that the management of depression in the con-
text of HIV care resulted in enhanced adherence to ART. 
Similar findings have been reflected in previous studies. 
In a 2017 cluster randomised controlled trial conducted 
in Uganda by Wagner and colleagues [37], depression 
treatment was associated with not only improved ART 
adherence but also retention in HIV care. Likewise, in a 
2014 meta-analysis by Sin and DiMatteo [38] examining 
the same association, it was found that the odds of ART 
adherence were 83% better if the HIV positive individual 
received depression treatment.
But also worth noting is that while the association 
between depression treatment and ART adherence has 
been noted in previous studies, our study builds further 
on this evidence base by characterising some of the path-
ways through which such treatment leads to adherence. 
These notably included enabling disclosure in discordant 
relationships, which created an environment in which 
the HIV positive spouse was no longer encumbered by 
the need for secrecy in administering ART, and was also 
able to leverage the support of the spouse, for example in 
the form of reminders, to ensure they do not miss their 
dose. We view this as an important contribution insofar 
as facilitating better programming for HIV counselling to 
minimise the incidence of depression among PLWHA.
We also highlighted self-efficacy as one of the benefits 
accruing from depression treatment. Stakeholders, par-
ticularly PLWHA, credited the treatment for having ena-
bled them to regain control over their lives by acquiring 
knowledge about a hitherto unknown disease (depres-
sion) they were suffering from, and by believing in their 
own agency in addressing their health problems. This 
finding echoes previous work as reported by Wagner 
et al. [37] in identifying the positive association between 
self-efficacy and ART adherence. But while Wagner et al. 
[37] point to the mediating role of self-efficacy, suggest-
ing no effect of depression treatment on self-efficacy, we 
show in this paper that self-efficacy itself can be one of 
the benefits of depression treatment.
But our findings notably also highlight stakeholders’ 
view that while acceptable, the feasibility of integrating 
the management of depression into routine HIV care 
would necessarily be predicated on some key interven-
tions. Guided by Benzer and colleagues’ [30] theoretical 
perspectives on factors influencing success of integrated 
care, we were able to identify organizational factors 
(namely training to develop clinical expertise), provider 
experiences (such as time pressures arising from redis-
tribution of workloads) and patient factors (improv-
ing depression awareness) as some of the key areas that 
needed to be addressed as a precondition for the success 
of integration. These findings, particularly on the need 
for training, build further on those from earlier studies 
that have cited absence of depression care and expertise 
in HIV care programs [9, 36, 39, 40], and highlighted the 
need for HIV care providers to develop capacity to diag-
nose and manage depression [36]. Consistent with these 
findings, studies in Tanzania and Cameroon have shown 
that training HIV care providers in prescription and 
management of antidepressants is effective at improving 
depression outcomes [41, 42].
Stakeholders also echoed findings from earlier work 
[43] by advocating change in the form of raising patient 
(and the broader community) awareness about depres-
sion as a way of improving understanding of the disease 
and uptake of relevant services in the context of HIV 
care. This finding lends further credence to Benzer and 
colleagues’ [30] theoretical perspectives on the role of 
patient factors (in this case, knowledge about depression) 
or what they conceptualise as the surrounding environ-
ment in shaping success of integration.
Furthermore, the overwhelmingly positive attitude that 
clinicians expressed towards integration was notable in 
light of their concerns about the increased workload. We 
consider this attitude significant inasmuch as it raises the 
prospect of uptake of the innovation among clinicians 
whose support is critically important for the success of 
the innovation.
In terms of informing the HIV + D trial, our formative 
work has informed the design of a more client-friendly 
decision support algorithm that provides for four steps 
rather than the three that were delivered during the 
formative research. The current algorithm provides for 
screening and psychoeducation at Step I; delivery of psy-
chotherapy at Step II to all participants whose depression 
scores remain high; delivery of both psychotherapy and 
antidepressants at Step III to those who scores are still 
high after Step II; and a referral to a mental health spe-
cialist at Step IV for those whose scores are persistently 
high after Step III.
Limitations of the study
Our study had some limitations. One of these is that data 
were collected from only four HIV clinics in one district 
in central Uganda. While we make inferences from this 
study that may be generalizable to HIV care in Uganda–
especially given the commonalities across the broader 
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public health care system in the country, including the 
profile of the clientele normally attending these public 
facilities–we caution that these results may not exhaus-
tively depict stakeholders experiences and perspectives 
across the country.
Another limitation of the formative study on which 
this paper is based is that the data collected on feasibil-
ity of the HIV + D integration model was qualitative and 
therefore did not include the economic aspect – the cost-
effectiveness analysis. In this formative study, our focus 
was on technical and operational feasibility. Formative 
cost effectiveness studies including the local validation of 
health economics study tools were later undertaken and 
will be reported in a separate paper.
Conclusion
Integrating the management of depression into routine 
HIV care in Uganda is acceptable among key stakehold-
ers (patients and clinicians), but the feasibility of this 
innovation would require some changes at the organisa-
tional and patient levels. We have shown in the paper that 
stakeholders, most importantly service users (patients), 
attribute a number of benefits to integration, including 
improvement of ART adherence, overcoming sleepless-
ness and suicidal ideation, and regaining a sense of self-
efficacy. We have also highlighted stakeholders’ concerns 
about the various challenges to integration, broadly cate-
gorised as organisational and patient-level factors, as well 
as their recommendations on how best to integrate. One 
key observation from our findings was that stakeholders 
who spoke most to the acceptability of integration were 
patients and clinicians. Acceptability among the patients 
was evident in the wide array of benefits they attributed 
to the HIV + D intervention in which they had a chance 
to experience integrated (depression and HIV) care. Sim-
ilarly, we have noted that some clinicians demonstrated 
acceptability by supporting integration in spite of the 
extra workload it engendered. We consider the perspec-
tives of these stakeholders an important indication of 
future uptake of integration considering that they are the 
most directly impacted and their cooperation arguably is 
critical for the success of integration. Given the paucity of 
research on service integration in sub-Sahara Africa [36] 
our findings will feed into the much needed knowledge 
base for the development of evidence-based and contex-
tually grounded models of integration.
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